Achieving Sustainable Health: What is the Wegovy Shot and How Does It Work?

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by activating appetite-control centers in the brain and slowing stomach emptying. Originally developed for type 2 diabetes management, clinical trials show patients using semaglutide experience an average weight loss of 15–22% of their starting body weight over 68 weeks. PlexusDx makes this proven therapy accessible through compounded semaglutide injections from licensed 503A pharmacies, with pricing that stays flat regardless of dose adjustments.

How Semaglutide Injections Regulate Appetite and Weight

Semaglutide activates GLP-1 receptors throughout your body, triggering signals that tell your brain you feel satisfied after eating smaller portions. This mechanism reduces the reward-driven desire to eat between meals and lowers overall calorie consumption without requiring willpower-based restriction. The medication also slows gastric emptying, meaning food stays in your stomach longer and hunger signals take hours to return.

Unlike stimulant-based diet pills that increase energy or anxiety, semaglutide works on your body's natural appetite regulation system. Research published in major endocrinology journals confirms that GLP-1 receptor activation produces durable weight loss because it addresses a root cause—dysregulated hunger signaling—rather than temporarily suppressing appetite. Most patients report that food cravings diminish naturally within the first two weeks of treatment initiation.

The Clinical Evidence Behind Semaglutide Injections

The landmark STEP trial series demonstrated that weekly semaglutide injections produced sustained weight reductions in over 4,500 adults with obesity. Participants receiving the highest dose lost an average of 22% of their starting weight, compared to 3% in the placebo group. Beyond weight loss, semaglutide significantly improved cardiovascular risk factors including blood pressure, triglycerides, and inflammation markers.

Long-term follow-up data shows that weight loss achieved during semaglutide treatment is maintained when patients continue therapy, and weight regain occurs gradually if treatment stops—unlike older approaches where rapid rebound was common. These findings support semaglutide as a legitimate medical intervention for chronic weight management, not a temporary diet tool. PlexusDx prescribers are trained to monitor these clinical outcomes and adjust treatment protocols based on individual response.

Compounded Semaglutide vs. Brand-Name Options at PlexusDx

PlexusDx sources semaglutide from licensed 503A compounding pharmacies, which manufacture the medication under the same FDA-oversight standards required for larger manufacturers. Compounded semaglutide injections contain the identical active ingredient as brand-name versions but cost significantly less because compounding facilities do not bear the marketing, distribution, and patent-protection expenses of major pharmaceutical companies. PlexusDx's flat monthly pricing structure—at $189/mo month-to-month, or from $149/mo on the 6-month plan—remains consistent whether your dose is 0.25 mg or 2.4 mg weekly.

All semaglutide injections from PlexusDx are accompanied by sterile needles, clear dosing instructions, and access to licensed providers for dose adjustments and side-effect management. The medication is delivered to your home in insulated packaging, and PlexusDx maintains cold-chain integrity throughout shipping. Patients in all 50 states can access treatment without insurance, and PlexusDx medications are HSA/FSA eligible, further reducing out-of-pocket costs.

Personalizing Your Semaglutide Treatment with Genetic Testing

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the difference between a semaglutide injection and an oral tablet?

Semaglutide injections are administered once weekly under the skin and have higher bioavailability, meaning more of the active ingredient reaches your bloodstream compared to oral tablets. Injections typically produce faster appetite reduction and more consistent blood levels. PlexusDx offers both compounded semaglutide injections (at $189/mo month-to-month, or from $149/mo on the 6-month plan) and oral semaglutide (at $289/mo month-to-month, or from $249/mo on the 6-month plan), allowing you to choose based on preference, lifestyle, and clinical goals.

How quickly will I see weight loss results from semaglutide?

Most patients notice decreased hunger within 3–7 days of starting semaglutide, though measurable weight loss typically appears after 2–4 weeks as calorie reduction accumulates. Maximal results are usually achieved over 12–16 weeks once you've reached your maintenance dose. Clinical data shows average weight loss of 1–2 pounds per week, with faster initial loss followed by gradual, steady loss over several months.

How much does PlexusDx compounded semaglutide cost per month?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and remain at that flat price regardless of your dose—whether you're on 0.25 mg or 2.4 mg weekly. No insurance is required, and the medication is HSA/FSA eligible. PlexusDx serves all 50 states with no membership fees.

What are the common side effects of semaglutide injections?

Nausea is the most frequently reported side effect, occurring in 20–40% of patients during the initial weeks and typically resolving within 1–2 months. Other common effects include mild constipation, reduced appetite for foods you previously enjoyed, and occasional fatigue. Serious side effects are rare but can include pancreatitis symptoms; your PlexusDx provider will screen for risk factors before treatment and monitor you throughout.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy Shot
• How Do Genetics Affect Liver Health And Ast Levels And How Can Testing Help Manage It
• How Does It Affect Fertility Bone Health Vitality And Genetics
• Benefits Of Lutein For Eye Health And How To Include It In Your Diet

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.